Photo therapy for Permanent Treatment of Parkinson’s Disease

-From symptomatic treatment to permanent treatment without electrical deep brain stimulation, infection, or side effects-

Toward a Lasting Cure for
Parkinson’s with Photo therapy

 

By inserting an optical device into relevant deep brain regions and delivering targeted optical stimulation—rather than electrical stimulation—to the therapeutic neural circuits,synaptic plasticity is induced, thereby repairing the neural pathways.

Because the device integrates both optical stimulation and optical measurement,1diagnosis and therapeutic assessment can be completed within a single procedure.1This eliminates the need to leave the device implanted in the body,allowing its removal immediately after surgery.

Through this innovative optical therapy, which combines diagnosis and treatment within the living body, patients are freed from implanted devices and their associated side effects.

 

[Benefits of Optical Therapy]

Permanent Treatment: Conventional Parkinson’s disease therapies are symptomatic, but optical therapy induces synaptic plasticity, restores neural circuits, and enables permanent treatment of the disease.

No Implanted Device Required: By integrating diagnosis and treatment within the body, DBS optical therapy frees patients from implanted electrical DBS devices and their side effects.

 


The PhotN project helps Parkinson's disease patients regain their daily lives

PhotoN Project Overview

【Objective】 
Permanent Cure for Parkinson’s Disease through Optogenetics-Based「Optical Therapy」 

【Advantage】
• Permanent Treatment:Optical therapy restores neural circuits for lasting cure of Parkinson’s disease.
• No Implants Needed:Optical therapy integrates diagnosis and treatment, freeing patients from implanted devices and side effects.

【Patients】
• 13M Parkinson’s patients worldwide. Advanced-stage patients rely on electrical DBS implants.Market: $1.46B (2024) → $3.20B by 2033.
 

【Seed Technology】
Combining (1) optogenetic therapy for Parkinson’s disease andと、②Optical devicesto realize innovative medicine.

光で永続的治療を実現
現状の電気DBSの問題

This meeting sparked the opportunity 

Jun Ohta

Optical Bio-Device Pioneer

 Jun Ohta


Director and Vice President, NAIST

Fellow of the
A large grant winner (Substrate S)
Medal with Purple Ribbon
 

Fumiaki Yoshida

Leader of Brain Opto Genetics

Fumiaki Yoshida


Brain & Neurology Professor, Kurume Univ

Neurosurgeon specializing in DBS,
with 1,000+ clinical cases.
Pioneered optogenetics in primates at MIT.
Researched neural network disorders at Oxford.

Masahiro Osawa

Multi-level brain analysis

Masahiro Osawa


Pharmaceutical Sciences Professor, Teikyo Univ

Research targeting the root causes of central nervous system disorders.
Exploring therapies with the potential to cure CNS diseases once considered untreatable.
 
 

PhotoN Project
Contact: Motoshi Sobue
info@photn.net

en_USEnglish
Powered by TranslatePress